For example, some indications have emerged that prostate tumors with high levels of vitamin D (1,25-dihydroxyvitamin D3) receptors (VDR) are twice as likely to be TMPRSS2-ERG fusion-positive than those with the low VDR levels[39]. Here, ERG is linked to prostate neoplasm.